Fused extracellular vesicles from M 2 macrophages and human umbilical cord mesenchymal stem cells for the targeted regulation of macrophage pyroptosis in periprosthetic osteolysis
Journal of Extracellular Vesicles · 2024
DOI: 10.1002/jev2.70028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2024. Verfasst von Qimeng Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Mesenchymal Stem Cells, Osteolysis, Macrophages. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The development of strategies for the prevention and treatment of aseptic loosening of prostheses stands as a critical area of global research interest. The pyroptosis of local macrophages triggered by wear particles plays a pivotal role in the onset of periprosthetic osteolysis and subsequent loosening. Extracellular vesicles, carrying the surface components and regulatory molecules of their parent cells, embody the cellular characteristics and biological functions of these progenitors. In a pioneering approach to precisely inhibit the pyroptosis of local macrophages induced by wear particles, we have engineered fused extracellular vesicles (fEV) from M 2 macrophages and human umbilical cord mesenchymal stem cells. These fEV boast the distinctive capability for targeted transport and immune evasion, collectively enhancing the anti‐pyroptosis effect of the therapeutic extracellular vesicles. Our research demonstrates the targeted, significant preventive and therapeutic potential of fEVs against periprosthetic osteolysis prompted by wear particles, highlighting its crucial clinical significance and application prospects. These findings suggest that extracellular vesicle fusion technology heralds a novel paradigm in the design and development of targeted extracellular vesicle‐based drug delivery systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, China.
ORCID-Profile: Jie Xie
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Liu, Q., Ma, T., Zhang, Z., Nan, J., Liu, G., Yang, Y., Hu, Y., & Xie, J. (2024). Fused extracellular vesicles from M 2 macrophages and human umbilical cord mesenchymal stem cells for the targeted regulation of macrophage pyroptosis in periprosthetic osteolysis. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70028
Vancouver
Liu Q, Ma T, Zhang Z, Nan J, Liu G, Yang Y, et al. Fused extracellular vesicles from M 2 macrophages and human umbilical cord mesenchymal stem cells for the targeted regulation of macrophage pyroptosis in periprosthetic osteolysis. Journal of Extracellular Vesicles. 2024. doi:10.1002/jev2.70028
BibTeX
@article{Liu2024,
author = {Liu, Qimeng and Ma, Tianliang and Zhang, Zheyu and Nan, Jiangyu and Liu, Guanzhi and Yang, Yute and Hu, Yihe and Xie, Jie},
title = {Fused extracellular vesicles from M 2 macrophages and human umbilical cord mesenchymal stem cells for the targeted regulation of macrophage pyroptosis in periprosthetic osteolysis},
journal = {Journal of Extracellular Vesicles},
year = {2024},
doi = {10.1002/jev2.70028}
}
EUVIMED